Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)

Pyoderma Clinical Trial

Official title:
Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas

Status Withdrawn

Clinical Trial Summary

This open-label, randomized, parallel-group clinical study is designed to compare the efficacy and safety of the topical antibiotic, sisomicin cream, with that of another topical antibiotic cream, nadifloxacin cream, in the treatment of Indian patients with primary pyodermas.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Pyoderma

Clinical Trial Details

NCT number	NCT00202891
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Withdrawn
Phase	Phase 4
Start date	May 2007
Completion date	September 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00884728` - Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory	N/A
Recruiting	`NCT04901325` - Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)	Phase 2
Completed	`NCT04895566` - Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma	Early Phase 1
Completed	`NCT05561816` - Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma	Phase 3
Recruiting	`NCT02280733` - A Real World, Observational Registry of Chronic Wounds and Ulcers